Ligand Pharmaceuticals Inc
NASDAQ:LGND
Wall Street
Price Targets
LGND Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
LGND
is 248.31 USD
with a low forecast of 222.2 USD and a high forecast of 288.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LGND's stock price target?
Price Target
248.31
USD
According to Wall Street analysts, the average 1-year price target for
LGND
is 248.31 USD
with a low forecast of 222.2 USD and a high forecast of 288.75 USD.
What is Ligand Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
23%
For the last 13 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's revenue is
14%.
The projected
CAGR
for the next 4 years is
23%.
What is Ligand Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
65%
For the last 13 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's operating income is
21%.
The projected
CAGR
for the next 4 years is
65%.